Mycophenolate mofetil Completed Phase 3 Trials for Mantle Cell Lymphoma (MCL) / Recurrent Plasma Cell Myeloma / Myelodysplastic Syndrome / Leukemia, Prolymphocytic / T-cell chronic lymphocytic leukaemia / Aggressive Non-Hodgkin Lymphoma / chronic, recurrent Lymphocytic Leukemia / Hematopoietic and Lymphoid Cell Neoplasm / Leukemia Acute Myeloid Leukemia (AML) / Refractory Hodgkin Lymphoma / Chronic Lymphocytic Leukaemia (CLL) / Lymphoma, Large B-Cell, Diffuse (DLBCL) / Acute Lymphoblastic Leukaemias (ALL) / Small Lymphocytic Lymphoma (SLL) / Waldenström's Macroglobulinemia (WM) / Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive / Chronic Lymphocytic Leukemia (CLL) - Refractory / Myeloproliferative Neoplasms / Indolent Non-Hodgkin's Lymphomas Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT01231412Graft-Versus-Host Disease Prophylaxis in Treating Patients With Hematologic Malignancies Undergoing Unrelated Donor Peripheral Blood Stem Cell Transplant
NCT02461121HLA-mismatched MST vs HLA-matched NST for AML in Intermediate-risk